AstraZeneca的疫苗被n个EU国家停止了,打完可能成为脑血栓吴老二。

billwanhua

本站元老
注册
2005-07-07
消息
4,039
荣誉分数
1,060
声望点数
373
79%--->76% 依然不错。为什么要搞数据操作“data cherry-picking”
最重要的“100% effective against severe disease and hospitalization.”。这个疫苗不错,两个mRNA疫苗也没有100%

The findings suggest the vaccine is more effective in patients aged 65 and older than previously understood, with a newly reported efficacy rate of 85% for that population, up from a previously stated 80%.


如果这个是真的,这个疫苗我排在第一个选择

说不定这个疫苗反而是好疫苗,由于政治原因,被美国和欧洲拿到放大镜下审查,问题起码不会比俩个mRNA 疫苗大,我们谁听过欧美对那俩个疫苗的质疑?
 
最后编辑:

lindamy

时代广场舞照跳
VIP
注册
2005-11-23
消息
23,158
荣誉分数
5,514
声望点数
373
3 hr 2 min ago

"One mistake after the other." How AstraZeneca went from pandemic hero to villain​

From CNN Business' Julia Horowitz in London

After teaming up with Oxford University, AstraZeneca produced a safe and effective Covid-19 vaccine in just nine months, a huge achievement that will help end the pandemic. But a series of missteps along the way has led to scathing criticism from policymakers and health officials, tarnishing the company's image as a hero of the coronavirus era.

The Anglo-Swedish drugmaker mistakenly gave some volunteers a half dose of the vaccine during clinical trials, and it has been criticized for omitting crucial information from its public statements. US regulators have questioned the accuracy of its vaccine data, and severe production delays in Europe have resulted in a political firestorm and a breakdown in relations with EU leaders.

"What we have with AstraZeneca is a company that is not straightforward, that cannot be relied upon," Philippe Lamberts, a Belgian member of the European Parliament, said in a radio interview with the BBC on Wednesday.

AstraZeneca's (AZN) failure to deliver tens of millions of promised doses to the European Union, which is struggling to roll out vaccination programs, led the bloc to impose export restrictions that have already prevented at least one shipment of vaccines to Australia. Leaders could move to make the restrictions even tighter Thursday.

Meanwhile, the US National Institute of Allergy and Infectious Diseases expressed concerns earlier this week that AstraZeneca had presented "outdated" data from a trial of the vaccine's effectiveness. Dr. Anthony Fauci, the agency's director, called it "an unforced error" that could erode trust in a "very good vaccine."

AstraZeneca updated its data on Thursday, reporting that the trials showed its vaccine to be 76% effective in preventing Covid-19 symptoms. Earlier this week, it had said its shot was 79% effective. The rare rebuke from US regulators was a major blow to the company's credibility.

"They've made one mistake after the other," said Jeffrey Lazarus, head of the health systems research group at the Barcelona Institute for Global Health.
Read more:

'One mistake after the other.' How AstraZeneca went from pandemic hero to villain
RELATED

'One mistake after the other.' How AstraZeneca went from pandemic hero to villain

 

向问天

日月神教光明左使
VIP
注册
2012-09-04
消息
60,488
荣誉分数
10,998
声望点数
1,273

希腊1女接种AZ疫苗…20分钟后死在公园​

ETtoday 03-31 23:24+-
血栓风波似乎仍未平息,希腊一名63岁妇人于3月30日接种AZ疫苗的20分钟后,就被人发现躺卧公园,几无生命迹象,送医后死亡。
image.png

▲英国药厂阿斯利康(AstraZeneca)与牛津大学共同研发的AZ疫苗引发血栓形成疑虑。(图/路透)

根据《Europe1》报导,希腊63岁妇人30日在雅典西郊一家健康中心接种AZ疫苗,却在20分钟后被人发现昏倒在公园长椅,到院后随即被宣布死亡。据悉,这名妇人患有糖尿病与其他慢性病,疑似因为发生严重血栓而死亡,希腊卫生部下令进行相验,以确定死因是否与疫苗有关,但初步认定疫苗并非猝死主因,因为血栓不会在这麽短的时间内形成,而其他副作用也很难瞬间致命。

另有消息指出,法医发现死者有心脏问题与肺水肿,可能是急性心肌梗塞导致妇人猝死。此前,阿斯利康(AstraZeneca)药厂研发的新冠肺炎疫苗爆出可能引发血栓形成,导致瑞典、芬兰、法国加拿大等都已暂停提供年轻族群施打,德国也宣布跟进,希腊则从未停打,且只允许65岁以下民众接种AZ疫苗。
 
顶部